Familial pituitary tumors are increasingly recognized. While some of these cases are related
to well-known syndromic conditions such as multiple endocrine neoplasia type 1 (MEN1) or …

Nonfunctional pituitary adenoma (NFPA) is highly heterogeneous with different hormone‐
expressed subtypes in NFPA tissues including follicle‐stimulating hormone (FSH) positive …

Gonadotroph nonfunctioning pituitary adenomas (NFPAs) are common intracranial tumors,
but the role of aberrant epigenetic regulation in their development remains poorly …

Prolactinomas are the most frequent functioning pituitary adenomas, and sex differences in
tumor size, behavior and incidence have been described. These differences have been …

Telomerase reverse transcriptase (TERT) expression is a hallmark in tumorigenesis and
upregulated due to mutations and methylation of the human (h) TERT promoter. As …

Dopamine (DA)-agonist targeting of the DA D2 receptor (D2R) in prolactinomas is the first-
line treatment choice for suppression of prolactin and induction of tumor shrinkage …

Predicting pituitary tumor behavior remains a challenge, since the prognostic value of
identified pathological markers has not yet been evaluated. Genome-wide transcriptome …

Epigenetic changes, which target DNA and associated histones, can be described as a
pivotal mechanism of interaction between genes and the environment. The field of …

Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …

Total thyroidectomy and central neck dissection are the procedures of choice in patients
affected with medullary thyroid cancer. It is known that a medullary thyroid cancer with node …